Patent · US Active

CRISPR/Cas9 complex for genomic editing

US11643668B2 · kind B2 · utility

0Cited by
18References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 17, 2016
Grant dateMay 9, 2023
Priority date—
Expiry dateNov 2, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are CRISPR/Cas9 complexes and method of using same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.